From Doubt to Breakthrough

Post a challenge. Clarify the pain point. Get feedback from scientists, industry and investors — asynchronously.

🎯

Articulate the Pain

Structured questions guide you to clarify the real problem, who feels it, and why current solutions fail

💬

Ecosystem Feedback

Peers validate the pain, experts assess feasibility, investors evaluate market size — async, thoughtful

🔗

Async Collaboration

Comment threads, shared docs, and async syncs across time zones and disciplines

Ecosystem

🏭

Multinationals / Regional

Bayer, BASF, Sartorius — biomanufacturing, advanced materials, supply chain

BiomanufacturingDeepTech
🚀

BioTech Startups

Luyef, Tomorrow Foods, Elemental Foods, Moka Bio, Startup Awards

FoodTechSynBio
🔬

Research Institutions

CONICET (prelaunch), GALTEC — R&D, technology transfer

AcademiaGovernment
💰

Venture Capital

GRIDX+Criteria+Zentynel, Ganesha Lab, Danta, Emerge Brasil

VC
⚖️

Policymakers & Regulators

Biotech regulation tracking, Nagoya Protocol, compliance and public policy

RegulationNagoyaCompliance

Program Tracks

🤖 AI/Bio & DeepTech 🏭 Biomanufacturing 🌱 Food & Sustainability 🧬 From Science to Startup

Post a Challenge

Articulate a real pain point or unmet need in biotech. Get feedback from the ecosystem before you invest months building.

How to post a challenge

① What pain are you solving?

Describe the specific pain or unmet need. Who feels it? How often? What does it cost them today?

② Why hasn't it been solved?

What have you or others tried? Why didn't those attempts work? What's the gap?

③ What does a good solution look like?

Imagine the ideal solution working. What happens differently? How do you measure "fixed"?

④ Who needs to be involved?

Which roles, disciplines, or institutions must collaborate? What expertise or resources are essential?

⑤ AI Clarity Check

Before publishing, the platform evaluates: pain specificity (2-4), unmet need clarity (1-3), solution clarity (1-3), and completeness. You get a score and can revise before publishing.

Example: Published Challenge

🧬 Low-cost enzyme stabilization for small-scale biofertilizers
Food & Sustainability
THE PAIN
"Small organic farmers in Argentina lose 30-40% of their biofertilizer investment because the microbial cultures die during transport and storage. The few stabilization methods that exist cost more than the product itself."
✍️ 5 clarifications 💬 12 feedback 🤝 3 collabs
Recent Challenges from the Ecosystem
🧬 Enzyme stabilization for small-scale biofertilizers DM Dra. M. López · CONICET
🎯 Pain 4/4 ❓ Unmet 3/3 💡 Solution 2/3 📊 Completeness 9.2
THE PAIN
"Small organic farmers in Argentina lose 30-40% of their biofertilizer investment because microbial cultures die during transport. Existing stabilization costs more than the product. We need a low-cost, shelf-stable formulation."
Why unsolved: Lyophilization is too expensive at scale. No one in LATAM has tried spray-drying with cost-effective carriers.
Who's needed: Formulation scientist, agricultural economist, pilot plant access in Argentina or Brazil.
💬 12 feedback 👍 23 📌 Save 🤝 Collaborate → View feedback
🏭 Carbon tax compliance for mid-size biomanufacturers JH James H. · Sartorius
🎯 Pain 4/4 ❓ Unmet 2/3 💡 Solution 2/3 📊 Completeness 8.4
THE PAIN
"EU carbon border adjustments hit LATAM biomanufacturers hard. We calculate emissions correctly but the reporting burden is 200+ hours/year. Competitors in Asia get subsidies for the same work."
Why unsolved: Generic ESG tools don't cover bioprocess specificity. Industry hasn't built a dedicated calculator.
Who's needed: Carbon accounting specialist, bioprocess engineer, policy advisor, SaaS developer.
💬 8 feedback 👍 15 📌 Save 🤝 Collaborate → View feedback
platform.biotech-innovation.com/challenges/new
Challenge Form
① What pain or unmet need are you addressing?
Be specific: who feels it, how often, what does it cost?
8/10
② Why hasn't this been solved yet? What have you tried?
What failed? Why? Where's the gap between current attempts and what's needed?
6/10
③ What does a good solution look like?
What changes? How do you know it's working? What's the minimal viable answer?
8.5/10
④ Who needs to be involved? What expertise/resources are essential?
List roles, disciplines, institutions. Be specific about what each contributes.
AI Clarity Score
9
Pain Specificity
8
Unmet Need
6
Why Unsolved
9
Solution Clarity
Feedback & Suggestions:
✅ Pain is specific: quantifies impact (30-40%), identifies affected group
✅ Solution target is measurable: >90% viability, 4 weeks, $2/L
⚠️ Consider: What's the TAM? How many farmers would this serve? This strengthens the business case for VC feedback.

Feedback Panel

Asynchronous structured feedback from the ecosystem. Every challenge gets feedback from peers, experts, and investors.

🧬 Low-cost enzyme stabilization for small-scale biofertilizers
Posted 3 days ago · 12 feedback · 3 collabs · Food & Sustainability track
9.2 / 10 Clarity
9/10 Pain quality
8/10 Validation
3 New collabs

Feedback Threads

DM
Dra. María López
Expert · Enzyme Engineering · CONICET
Expert 2h ago
💡 Helpful (5) 🔬 Validate (3) ❓ Clarify (1)
Strong pain articulation. Have you considered thermostability of the variant under industrial conditions? I've seen similar mutations lose activity above 60°C. Could test at different temps. I can run a preliminary assay on our platform — ping me if you want to connect.
💬 2 replies 👍 5 📌 Save 🤝 Invite to collab
💡 Helpful 🔬 Validate ❓ Clarify ⚠️ Risk 🤝 Collab offer
RP
Ricardo P.
VC Partner · Ganesha Lab Fund
VC 5h ago
💡 Helpful (7) 📊 Market interest (4) 🔬 Validate (2)
Interesting space. What's the path to first customer? Are you targeting small farmers or distributors? The TAM is significant but go-to-market will define the investor thesis. Would you share a rough SAM estimate?
💬 3 replies 👍 7 📎 Link to deck 🤝 Invite to collab
💡 Helpful 📊 Market interest ❓ Clarify ⚠️ Risk 🤝 Collab offer
JH
Dr. James H.
Industry · Sartorius Bioprocessing
Industry 1d ago
🤝 Collab offer (3) 🔬 Validate (2) 💡 Helpful (1)
We run a pilot program for external enzyme innovations. If your formulation pathway shows promise, we could discuss a validation project at our Hamburg site. Would a 100L bioreactor trial help?
💬 1 reply 👍 9 🤝 Accept collab
💡 Helpful 🔬 Validate ❓ Clarify ⚠️ Risk 🤝 Collab offer
AL
Ana L.
Policymaker · Ministry of Agriculture, Argentina
Regulator 2d ago
📊 Market interest (2) 💡 Helpful (1)
This could support our national bioeconomy strategy. Are you aware of any biosafety regulations that might affect microbial culture transport within Argentina? We could explore a regulatory sandbox.
💬 0 replies 👍 3 🤝 Invite to collab
💡 Helpful 🔬 Validate ❓ Clarify ⚠️ Risk 🤝 Collab offer
Reply to this thread
💡 Helpful 🔬 Validate ❓ Clarify ⚠️ Risk 🤝 Collab offer

Dashboard

CONICET · Researcher
CM
Carmen M.
Challenges posted
3
↑ 1 this month
Feedback received
28
↑ 8 new
Connections made
5
↑ 2 this week
Avg. clarity score
8.7
↑ from 7.2

Recent Challenges

ChallengeTrackFeedbackCollabs.Clarity
Enzyme stabilizationFood & Sust.1239.2
Low-cost bioreactorBiomanufacturing927.6
Carbon compliance toolAI/Bio506.8

New Feedback

FromTypeNote
M. López (CONICET)Expert💡 3 suggestions
J. Harris (Sartorius)Industry🤝 Pilot offer
R. Patel (Ganesha)VC❓ Clarification

Recent Connections

NameAffiliationAction
🤝 María LópezCONICETCollab accepted
📎 Ana K.Moka BioData shared
🏭 James H.SartoriusPilot offered

Enterprise

White-Label

innovation.biopharm.com
BioPharm Innovation

Innovation Hub

Where challenges become partnerships

Domain:innovation.biopharm.com
Logo:biopharm-logo.svg
Color:#00b894

Webhooks & Integrations

hooks.slack.com/...Active
challenge_published, feedback_received, collab_requested · 200 OK · HMAC ✓
api.jira.com/webhook/...Retry
collab_accepted, challenge_approved · 500 Error · Retry 2/5

SOP & Governance

Policy: IP OwnershipApprovedJan 2027
SOP: Feedback QualityApprovedFeb 2027
Policy: NDA Auto-SignDraft—

Multi-Tenant

CONICET
sa-east-1 · SAML
● Active
BioPharm
us-east-1 · Enterprise
● Active
Backup DR · Data portability · Export: CSV/PDF

Startup View

Your challenges, feedback received, and collaboration opportunities — one place.

🧬Ginkgo Bioworks
Active
Synthetic Biology · Microbiome Engineering · 4 active challenges · 32 feedback received
4 challenges
32 feedback
4 collabs
8.1 avg. clarity

Recent Challenges

ChallengeTrackFeedbackPainClarity
Phage therapy platformAI/Bio124/49.1
Algae carbon captureFood & Sust.84/47.8
Microbial protein strainBiomanufacturing63/46.5
platform.biotech-innovation.com/startups/ginkgo

Ecosystem Connections

🤝 María L. · CONICET
Enzyme collaboration · 3 shared insights
● Active collab
🏭 James H. · Sartorius
Pilot program offer · 2 feedbacks
📎 Pilot offered
💰 Ricardo P. · Ganesha
Investment interest · Ask follow-up
❓ Pending reply